Summit Therapeutics Inc vs Verizon Communications Inc — how do they compare? Summit Therapeutics Inc trades at $14.57 (market cap $10.48B), while Verizon Communications Inc trades at $43.73 (market cap $181.64B). The key difference: Verizon Communications Inc is far larger — about 17.3× Summit Therapeutics Inc's market cap, and Verizon Communications Inc pays a 6.51% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| SMMT | VZ | |
|---|---|---|
Market Cap | $10.48B | $181.64B |
Sector | Health | Media |
52-Week High | $29.32 | $51.38 |
52-Week Low | $13.05 | $38.40 |
Enterprise Value | $9.90B | $369.14B |
Volume | — | 22,584,735 |
Dividend Yield | — | 6.51% |
Trailing returns across standard periods
Latest headlines on both assets
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →Verizon Communications Inc. is an integrated telecommunications company that provides wire line voice and data services, wireless services, Internet services, and published directory information. The Company also provides network services for the federal government including business phone lines, data services, telecommunications equipment, and payphones.
Read more on VZ →